5.7 Million People Now Receive Prescription Drug Coverage Through UnitedHealth Group's Medicare Part D Drug Plans.

MINNEAPOLIS -- Approximately 1 out of Every 3 Medicare Beneficiaries Enrolled in a Stand-Alone Prescription Drug Plan or a Medicare Advantage Prescription Drug Plan Receive Coverage Through UnitedHealth Group 

After the conclusion of the initial enrollment period for the new Medicare Prescription Drug Program (Part D), more than 5.7 million Medicare beneficiaries are enrolled in plans offered by UnitedHealth Group.

Jackie Kosecoff, Chief Executive Officer of Ovations Pharmacy Solutions, said, "Part D is helping to ensure a better quality of life for millions of older Americans by improving access to affordable prescription drug coverage. We are grateful that so many people trust our plans to deliver high-quality prescription drug coverage." Ovations Pharmacy Solutions is a division of Ovations, the UnitedHealth Group business unit dedicated to serving older Americans.

Offering plans with no deductible, premiums at or below the national average, simple and predictable co-payments, an extensive network of more than 54,000 retail and independent pharmacies, access to drug formularies that include virtually all Part D-approved drugs, and the support of strong partners positioned the Company to achieve the following results:

--More than 4.5 million receiving Part D coverage through stand-alone prescription drug plans, including 3.2 million in the AARP MedicareRx Plan;

--More than 1.2 million receiving Part D coverage along with enhanced medical benefits through Medicare Advantage plans;

--More than 68 million prescriptions filled by members of our Part D plans, 55% of which were filled by dual-eligible and low-income individuals; and

--More than $5 billion in savings already on prescription drug costs, as compared to the usual and customary prices, on drugs dispensed for members of our Part D plans.

According to the Center for Medicare and Medicaid Services, more than 38 million Medicare beneficiaries now have comprehensive prescription drug coverage. Many Medicare beneficiaries without prescription drug coverage may still enroll in a Part D plan without penalty, including:

--People who turn 65 after May 15.

--People who qualify for extra financial help.

--People who live in an area affected by Hurricane Katrina.

--People who receive a notice that their current, "creditable" drug coverage is ending.

--People who move out of their plan's service area.

For all others, the next opportunity to enroll will be between November 15, 2006 and December 31, 2006. Medicare beneficiaries are strongly encouraged to consider the value of signing up when enrollment is re-opened in November. For those enrolling in a Part D plan after November 15, their coverage will be active starting January 1, 2007.

About UnitedHealth Group

UnitedHealth Group (NYSE:UNH) is a diversified health and well-being company dedicated to making health care work better. Headquartered in Minneapolis, Minn., UnitedHealth Group offers a broad spectrum of products and services through six operating businesses: UnitedHealthcare, Ovations, AmeriChoice, Uniprise, Specialized Care Services and Ingenix. Through its family of businesses, UnitedHealth Group serves approximately 70 million individuals nationwide. Learn more about UnitedHealth Group at www.unitedhealthgroup.com.

Forward-Looking Statements

This news release may contain statements, estimates or projections that constitute "forward-looking" statements as defined under U.S. federal securities laws. Generally the words "believe," "expect," "intend," "estimate," "anticipate," "project," "will" and similar expressions identify forward-looking statements, which generally are not historical in nature. These statements may contain information about financial prospects, economic conditions, trends and unknown certainties. We caution that actual results could differ materially from those that management expects, depending on the outcome of certain factors. These forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the results discussed in the forward-looking statements. Some factors that could cause results to differ materially from the forward-looking statements include: increases in health care costs that are higher than we anticipated in establishing our premium rates, including increased consumption of or costs of medical services; heightened competition as a result of new entrants into our market, and consolidation of health care companies and suppliers; events that may negatively affect our contract with AARP; uncertainties regarding changes in Medicare, including coordination of information systems and accuracy of certain assumptions; funding risks with respect to revenue received from Medicare and Medicaid programs; increases in costs and other liabilities associated with increased litigation, legislative activity and government regulation and review of our industry; potential consequences surrounding findings of our ongoing internal investigation, investigation by a committee of our independent directors and informal SEC inquiry into our stock option granting practices, as well as a subpoena from the office of the U.S. Attorney for the Southern District of New York requesting documents relating to stock option grants since 1999 and a request from the Internal Revenue Service for documents relating to the compensation of certain executive officers; uncertainty of results of pending civil litigation relating to our stock option granting practices; our ability to execute contracts on competitive terms with physicians, hospitals and other service providers; regulatory and other risks associated with the pharmacy benefits management industry; failure to maintain effective and efficient information systems, which could result in the loss of existing customers, difficulties in attracting new customers, difficulties in determining medical costs estimates and appropriate pricing, customer and physician and health care provider disputes, regulatory violations, increases in operating costs, or other adverse consequences; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and intangible assets recorded for businesses that we acquire; potential noncompliance by our business associates with patient privacy data; misappropriation of our proprietary technology; and anticipated benefits of acquiring PacifiCare may not be realized. This list of important factors is not intended to be exhaustive. A further list and description of some of these risks and uncertainties can be found in our reports filed with the Securities and Exchange Commission from time to time, including our annual reports on Form 10-K and quarterly reports on Form 10-Q. Any or all forward-looking statements we make may turn out to be wrong. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Except to the extent otherwise required by federal securities laws, we do not undertake to publicly update or revise any forward-looking statements.